Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

1.250

+0.050 (4.17%)

At close: Sep 26, 2025, 4:00 PM EDT

1.230

-0.020 (-1.60%)

After-hours: Sep 26, 2025, 7:26 PM EDT

Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $277.35 million as of September 26, 2025. Its market cap has decreased by -54.42% in one year.

Market Cap

277.35M

Enterprise Value

91.23M

1-Year Change

-54.42%

Ranking

#3566

Market Cap Chart

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $277.35M, a decrease of -90.37%. That is a compound annual growth rate of -28.54%.

Market Cap History

Date	Market Cap	% Change
Sep 26, 2025	277.35M	-37.90%
Dec 31, 2024	446.60M	-17.32%
Dec 29, 2023	540.17M	-40.45%
Dec 30, 2022	907.08M	-57.34%
Dec 31, 2021	2.13B	-39.95%
Dec 31, 2020	3.54B	11.80%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	650.45B
Johnson & Johnson	432.80B
AbbVie	389.72B
UnitedHealth Group	311.62B
Novo Nordisk	242.68B
Novartis AG	238.65B
Abbott Laboratories	232.44B
AstraZeneca	228.75B

Market Cap Rankings